Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-02-25
    E.g., 2018-02-25

Articles

11899 items
12:00 AM, Mar 02, 2000  |  BC Extra | Financial News

CV Therapeutics raises $175 million

CVTX raised $175 million worth of convertible subordinated notes, with a $26.3 million overallotment option. The notes bear 4.75 percent interest, mature in 2007 and convert into CVTX stock at $63.84 per share. CVTX was...
12:00 AM, Mar 01, 2000  |  BC Extra | Financial News

Proteome raises $8.1 million

Proteome (Beverly, Mass.) raised $8.1 million in venture financing from Boston Millennia Partners and William Blair Capital Partners. The company is an internet provider of gene and protein information databases....
12:00 AM, Mar 01, 2000  |  BC Extra | Financial News

Celera raises $855 million

CRA recorded the largest follow-on in biotech since 1994, raising $855 million through the sale of 3.8 million shares of the genomics company at $225 per share. Underwriters Morgan Stanley Dean Witter; Goldman, Sachs; SG...
12:00 AM, Mar 01, 2000  |  BC Extra | Financial News

Targeted Genetics raises $30.3 million

The gene therapy company sold 2.16 million shares at $14 per share in a private placement. Franklin Templeton Group; INVESCO Funds; Lone Pine Capital; International Biotechnology Trust; and Deerfield Management were investors, and Chase H&Q...
12:00 AM, Mar 01, 2000  |  BC Extra | Financial News

Biovail proposes offerings

Biovail (BVF; TSE:BVF) filed to raise $300 million worth of convertible subordinated preferred equivalent debentures in the U.S. with a $45 million overallotment option. The debentures will be due March 31, 2025. The company also...
12:00 AM, Mar 01, 2000  |  BC Extra | Financial News

Abgenix sells shoe

ABGX raised $68 million from the exercise of its 324,000 shares in the overallotment to its February follow-on, bringing the total raised in the deal to $496.5 million. Selling shareholder Cell Genesys (CEGE) raised $26.5...
12:00 AM, Mar 01, 2000  |  BC Extra | Financial News

Andrx announces stock split

ADRX's board of directors approved a 2-for-1 split of the company's shares for shareholders of record as of March 15. The split will occur on or about April 3. ADRX, a developer of oral controlled-release...
12:00 AM, Mar 01, 2000  |  BC Extra | Financial News

Flamel raises $12.8 million

Flamel (FLMLY), which is developing controlled-release drug delivery technologies, raised $12.8 million in a private placement. Investors included Biotechnology Value Fund and its affiliates; Alta BioPharma Partners; and Chase Capital Partners....
12:00 AM, Mar 01, 2000  |  BC Extra | Financial News

Access raises $12 million

AXCS raised $12 million through the sale of 4.8 million shares at $2.50 per share. Oracle Partners was the lead investor. AXCS was up $0.50 to $8 on the day....
12:00 AM, Mar 01, 2000  |  BC Extra | Financial News

Deutsche Banc begins Chiron coverage

Deutsche Banc Alex. Brown analyst Dennis Harp recommended a "buy", with a $74 target. He said CHIR is positioned to operate on a leaner infrastructure and lower cost base, which should allow growth of EPS...

Pages